Decoding the Evidence Mash Up:
Prenatal Diagnosis of Accreta and Plus Size VBAC

Jen Kamel, VBAC Facts Founder

With the rising cesarean rate worldwide, the rate of abnormal placentation is increasing. Given the high rates of maternal and neonatal mortality and morbidity associated with abnormally invasive placenta (AIP), and the multidisciplinary team required to generate the best outcome, prenatal diagnosis is critical so transfer of care can occur if necessary. We will review the available methods for AIP diagnosis, top ultrasound and MRI AIP signs, how these signs can change throughout pregnancy, identifying percreta, and more. Then we will pivot to the evidence on plus size VBAC examining maternal and neonatal outcomes, the impact of provider bias, strategies to reduce bias in your practice, and the two factors that impact uterine rupture outcomes the most among plus size parents.

Jen Kamel helps perinatal professionals, and cesarean parents, achieve clarity on VBAC through her educational courses, training programs, and consulting services. As the Founder of VBAC Facts® and a nationally recognized consumer advocate, her mission is to increase VBAC access through education, legislation, and amplifying the consumer voice. She travels the country training perinatal professionals as a California Board of Registered Nursing Continuing Education Provider, presents Grand Rounds at hospitals, and has works as a legislative consultant in several states focusing on midwifery legislation and regulations that threaten VBAC access. Over the years she has testified multiple times in front of the California Medical Board and legislative committees, educated legislators on the importance of VBAC access, and has served as an expert witness in a legal proceeding. She envisions a time when every pregnant person seeking VBAC has access to unbiased information, respectful providers, and community support so they can plan the birth of their choosing in the setting they desire.